Susan Miller - Comments

Latest Comments
Sarepta Tumbles On New Drug Data But Presents A Big Buying Opportunity
11 years ago
Thank you for an informative article. This most certainly does sounds like a great buying opportunity. But I'm concerned that much of your buy recommendation comes from the assumption that the delay rumors are based on the misunderstanding of the methods used for delivering RNA oligonucleotides. How can you be sure this was the reason? Can you please elaborate?
In this article: RNA, SRPT
481 to 481 of 481 comments
<<< 1 ... 47 48 49

Following (0)

Followers (0)

Stocks I follow

General Stats

Article Comments

Received: 0
Created: 0